Healthcare provider profile · identity verified

Robyn Laughlin, NP

Nurse Practitioner · STIGLER, OK · NPI 1801263678

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	121	42
Furosemide	Furosemide	121	36
Gabapentin	Gabapentin	120	35
Amlodipine Besylate	Amlodipine Besylate	114	37
Metformin Hcl	Metformin Hcl	105	35
Lisinopril	Lisinopril	98	31
Omeprazole	Omeprazole	91	28
Rosuvastatin Calcium	Rosuvastatin Calcium	90	28
Losartan Potassium	Losartan Potassium	85	26
Pantoprazole Sodium	Pantoprazole Sodium	84	29
Levothyroxine Sodium	Levothyroxine Sodium	65	23
Potassium Chloride	Potassium Chloride	65	20
Ozempic	Semaglutide	62	16
Tamsulosin Hcl	Tamsulosin Hcl	61	16
Metoprolol Tartrate	Metoprolol Tartrate	60	20
Azithromycin	Azithromycin	55	50
Carvedilol	Carvedilol	55	20
Tresiba Flextouch U-200	Insulin Degludec	53	12
Amoxicillin	Amoxicillin	50	44
Albuterol Sulfate Hfa	Albuterol Sulfate	49	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	49	12
Hydrochlorothiazide	Hydrochlorothiazide	47	15
Duloxetine Hcl	Duloxetine Hcl	45	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	44	13
Escitalopram Oxalate	Escitalopram Oxalate	44	13
Irbesartan	Irbesartan	42	16
Pregabalin	Pregabalin	41	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	39	14
Trazodone Hcl	Trazodone Hcl	37	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	36	30
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Simvastatin	Simvastatin	35	11
Tramadol Hcl	Tramadol Hcl	35	suppressed
Clopidogrel	Clopidogrel Bisulfate	33	13
Tizanidine Hcl	Tizanidine Hcl	33	suppressed
Allopurinol	Allopurinol	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	32	26
Jardiance	Empagliflozin	31	11
Meloxicam	Meloxicam	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Spironolactone	Spironolactone	29	suppressed
Celecoxib	Celecoxib	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	28	16
Metoprolol Succinate	Metoprolol Succinate	28	11
Prednisone	Prednisone	27	24
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Eliquis	Apixaban	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Lovastatin	Lovastatin	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	11
Buprenorphine Hcl	Buprenorphine Hcl	21	suppressed
Cefdinir	Cefdinir	21	18
Alprazolam	Alprazolam	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Clindamycin Hcl	Clindamycin Hcl	20	19
Ibuprofen	Ibuprofen	20	11
Metformin Hcl Er	Metformin Hcl	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	19	suppressed
Estradiol	Estradiol	18	suppressed
Rybelsus	Semaglutide	18	suppressed
Sertraline Hcl	Sertraline Hcl	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Nebivolol Hcl	Nebivolol Hcl	17	suppressed
Suboxone	Buprenorphine Hcl/Naloxone Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Cephalexin	Cephalexin	16	14
Januvia	Sitagliptin Phosphate	16	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	15	suppressed
Mupirocin	Mupirocin	15	12
Ondansetron Odt	Ondansetron	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Clonazepam	Clonazepam	12	suppressed
Metoprolol-Hydrochlorothiazide	Metoprolol/Hydrochlorothiazide	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Zubsolv	Buprenorphine Hcl/Naloxone Hcl	12	suppressed
Atenolol	Atenolol	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Lorazepam	Lorazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error